395901000: Moxisylyte (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Moxisylyte

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Moxisylyte
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Vasodilator (substance)\Moxisylyte

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Methylamine\Dimethylamine\Moxisylyte

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Methylamine\Dimethylamine\Moxisylyte

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2536605017 Moxisylyte en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3482745010 Moxisylyte (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

13021000188113 moxisylyte fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Moxisylyte	Is a	Alpha adrenergic receptor antagonist	false	Inferred relationship	Some
Moxisylyte	Is a	Alpha-1 adrenergic receptor antagonist	true	Inferred relationship	Some
Moxisylyte	Is a	Dimethylamine	true	Inferred relationship	Some
Moxisylyte	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-1 adrenergic receptor antagonist (disposition)	true	Inferred relationship	Some
Moxisylyte	Is a	Vasodilator (substance)	true	Inferred relationship	Some
Moxisylyte	Is a	Autonomic agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Thymoxamine adverse reaction (disorder)	Causative agent (attribute)	True	Moxisylyte	Inferred relationship	Some	1
Allergy to moxisylyte	Causative agent (attribute)	False	Moxisylyte	Inferred relationship	Some
Product containing moxisylyte (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Moxisylyte 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Thymoxamine hydrochloride [erectile dysfunction]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Thymoxamine hydrochloride [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Thymoxamine 0.5% preservative-free eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Product containing moxisylyte in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Product containing moxisylyte in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Topical oral thymoxamine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Product containing moxisylyte in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Allergy to moxisylyte	Causative agent (attribute)	True	Moxisylyte	Inferred relationship	Some	1
Moxisylyte 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some	1
Moxisylyte 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Moxisylyte	Inferred relationship	Some	1
Moxisylyte hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Moxisylyte	Inferred relationship	Some
Thymoxamine 0.5% conventional release eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Moxisylyte	Inferred relationship	Some
Moxisylyte 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Moxisylyte	Inferred relationship	Some	1
Product containing moxisylyte in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Product containing only moxisylyte (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Product containing only moxisylyte in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Product containing only moxisylyte in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1
Product containing only moxisylyte in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Moxisylyte	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2536605017	Moxisylyte	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3482745010	Moxisylyte (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
13021000188113	moxisylyte	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module